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Abstract
Background: There were few studies on the outcome of schizophrenia in developing countries. Whether the
outcome is similar to or different from developed world is still a point for research. The main aim of the current
study was to know if patients with early onset non affective psychosis can behave and function properly after few
years from start of the illness or not. Other aims included investigation of possible predictors and associated factors
with remission and outcome.
Method: The study prospectively investigated a group of 56 patients with onset of psychosis during childhood or
adolescence. Diagnosis made according to DSM-IV criteria and included; schizophrenia, psychotic disorder not
otherwise specified and acute psychosis. Severity of psychosis was measured by PANSS. Measures of the outcome
included; remission criteria of Andreasen et al 2005, the children’s global assessment scale and educational level.
Results: Analysis of data was done for only 37 patients. Thirty patients diagnosed as schizophrenia and 7 with
Psychotic disorder not otherwise specified. Mean duration of follow up was 38.4 +/- 16.9 months. At the end of
the study, 6 patients (16.2%) had one episode, 23(62.1%) had multiple episodes and 8 (21.6%) continuous course.
Nineteen patients (51.4%) achieved full remission, and only 11(29.7%) achieved their average educational level for
their age. Twenty seven percent of the sample had good outcome and 24.3% had poor outcome. Factors
associated with non remission and poor outcome included gradual onset, low IQ, poor premorbid adjustment,
negative symptoms at onset of the illness and poor adherence to drugs. Moreover, there was tendency of
negative symptoms at illness start to predict poor outcome.
Conclusion: Some patients with early onset non affective psychosis can behave and function properly after few
years from the start of the illness. Although remission is a difficult target in childhood psychosis, it is still
achievable.
Background
S c h i z o p h r e n i ai sas e r i o u si m p a i r m e n to fh i g h e rb r a i n
functions including behavior, thinking, perception, emo-
tions, and personality. It is one of the most disabling
disorders as it was classified by the world bank as the
fifth leading cause of years lost because of disability for
men and sixth for women [1]. Although childhood schi-
zophrenia is a rare disorder (approximately one in
10,000 children) [2], it may be more terrifying and debil-
itating condition for youth and family. Although the
study of early-onset variants of disorders often enables
the examination of a more genetically homogeneous and
less environmentally influenced disease condition, there
are little studies during childhood [3].
On the other hand, analyzing studies about the out-
come of schizophrenia beginning in childhood or ado-
lescence, one infers that the course and outcome is less
favorable than in adult schizophrenic psychoses. Overall,
it appears that schizophrenic adults were more likely to
achieve periods of improvement, a higher level of psy-
chosocial functioning and a better overall outcome [4-6].
Previous outcome studies of childhood schizophrenia
tried to describe the course and types of outcome [4-7].
Moreover, studies investigated other predictors of out-
come as the types of onset [8], duration of untreated
psychosis [9], premorbid adjustment [5,6] and cognitive
functions [3]. * Correspondence: ghadarefaat@gmail.com
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childhood schizophrenia 13.4 years after first admission;
they found that 77.8% of the former patients were still
in outpatient treatment. Compared to the general popu-
lation, the number of patients without a school gradua-
tion was relatively high (18.5%). Almost half of
participants still live with their parents (48.1%) or in
assisted or semi-assisted living conditions (33.3%). Only
1 8 . 5 %w e r ew o r k i n gi nt h eo p e nm a r k e t .W h i l eW e r r y
and his colleagues [7], investigated 30 former schizo-
phrenic patients 7 to 17 years after their first inpatient
treatment. Complete recovery was noted for only 23% of
their patients at follow-up.
Hollis [10] reported that about one-fifth of patients in
most studies have a good outcome with only mild
impairment, while at the other extreme about one-third
of patients are severely impaired requiring intensive
social and psychiatric support. Limitations of previous
studies included relative rarity of the disorder which
reflected on the small sample size. Diagnosis of the dis-
order was another limitation as many cases diagnosed
first as atypical or affective psychosis [11]. In addition,
previous studies included conditions other than schizo-
phrenia as schizoaffective disorder [6]. Other confound-
ing factors were co-morbidities and past history with its
consequences on outcome.
At the same time in developing countries especially
Arab countries, there were l i t t l ei fa n ys t u d yr e g a r d i n g
the outcome of childhood and adolescent onset psycho-
sis. Moreover, there is no data to know whether the out-
come of childhood schizophrenia was the same or
different from studies done in developed countries.
So the main aim of the current study was to answer
an important question which was “can patients with
early onset psychosis behave and function properly after
few years from start of the illness?” Other aims of the
study included investigation of short term course, psy-
chopathological and psychosocial outcome in a group of
early onset non-affective psychosis. Also, this study was
done to identify possible factors associated with good or
poor outcome.
Methods
Design
This work was a longitudinal prospective study done in
the period between January 2003 and June 2010.
Setting
The study done at Al-Amal complex for mental health,
Dammam, Kingdom of Saudi Arabia (KSA) after being
approved by the scientific and ethical committee of the
complex. A written informed consent was taken from all
patients and/or their caregivers.
Participants
Patients were recruited from the child psychiatry clinic
according to certain inclusion and exclusion criteria.
The patients’ group included patients with non affective
psychosis who got the disorder before age 18 years and
did not pass the same age. In order to make the sample
homogenous as much as possible exclusion criteria
included any DSM-IV axis I diagnosis from the follow-
ing disorders: schizoaffective, bipolar, major depression,
substance induced psychotic disorder in addition to
exclusion of cases with known organic pathology. How-
ever, patients with past history of epilepsy or febrile
convulsions were not excluded.
Timeline of the study
All patients presented to child and adolescence outpa-
tient clinic were screened for psychosis through the
general part of schedule for affective disorders and
schizophrenia for school aged children present and
lifetime version (K-SADS-PL) [12]. Ninety eight
patients were positive for psychosis so assessed again
in a second interview with the psychotic supplement of
K-SADS-PL. Those who complete the required tools of
the study and continued to follow up for minimal
duration 24 months were 37 patients. Initial assess-
ment was done two times by the two investigators who
are child psychiatrists with good inter-rater reliability
as Kappa was ≥ 0.8. Collection of statistically deter-
mined adequate sample was done in the period
between 2003 and 2008.
Initial assessment was done at first and second visits
to outpatient clinic (OPC) for all cases. The time
between first and second visit was maximum one week.
Follow up assessment was scheduled every 3 months all
through the study. Minimum requirement for the study
was one assessment every 6 months and follow up per-
iod of at least 2 years, otherwise considered as drop out.
Initial assessment included; 1) history taking and men-
tal state examination, 2) K-SADS-PL for diagnosis and
clinical assessment of psychotic symptoms [12], 3) Posi-
tive and negative symptoms scale (PANSS) for assess-
ment of severity of psychosis [13], 4) IQ evaluation via
Stanford Binet intelligence test (Arabic version [14], 5)
Lewis Murray scale for assessment of obstetric compli-
cations [15], 6) Children’s global assessment scale
(CGAS) for evaluating the level of general functioning
[16], 7) General developmental scale [6], 8) Child beha-
vior scale (CBS)[17] and lastly 9) pre morbid adjustment
scale (PAS) [18].
Assessment at follow up visits included; history taking
and mental state examination, PANSS, the children’s
global assessment scale (CGAS), Andresen et al remis-
sion criteria [19].
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measures; Andresen et al remission criteria [19], global
assessment scale and level of educational achievement.
Assessment instruments
Many studies tried to answer the main study question
but most of them chose sophisticated measures as neu-
ropsychological testing and neuroimaging techniques
[3,4,7]. Actually these measures are not used in routine
clinical practice and in many developing countries there
are no trained personnel to use such measures if avail-
able. That’s why the investigators in the current study
chose to assess behavior and brain functions of patients
through more simple clinical bed side measures (chil-
dren’s global assessment scale, remission criteria of
Andreasen et al [19] and level of education). These mea-
sures although simple, they are objective and have good
sensitivity, specificity and reliability and can be used
routinely and objectively to reflect the level of
psychopathology.
The PANSS or the positive and negative syndrome
scale [13] is a scale used for measuring symptom sever-
ity of patients with schizophrenia. The PANSS is a rela-
tively brief interview, requiring 45 to 50 minutes to
administer.
The children’s global assessment scale (CGAS) [16], a
measure of overall severity of disturbance, is an adapta-
tion of the global assessment scale for adults. Findings
indicate that the CGAS can be a useful measure of over-
all severity of disturbance. The scale has a numeric
value (0 through 100) and used to rate the social, occu-
pational, and psychological functioning of patients.
Higher scores indicate better functions and were used in
many studies to reflect the ability of the brain to per-
form and adapt to psychosocial functions.
GDS [6] was used to record early childhood develop-
mental delay and neuro-developmental problems and
covered seven areas: motor milestones, language mile-
stones, social development, reading problems, neuro-
developmental problems, enuresis and encorporesis. The
total GDS score range from 0 to 12 and higher scores
indicate more developmental impairments.
CBS [17] was used for rating of the premorbid period
which ends 12 months before the onset of the first psy-
chotic symptoms. The scale has 10 aspects: social isola-
tion, social aloofness, separation anxiety; unusual
stereotyped interest, deviant social communication,
affect, suspiciousness, thought content, deviant speech
and antisocial behavior. Total CBS Score is 0-20 and
higher scores indicate more premorbid impairments.
PAS [18] is consisted of 28-items and assesses socia-
bility and withdrawal, peer relationships, adaptation to
school, and scholastic performance in four life stages
(childhood, early adolescence, late adolescence;
adulthood). Higher scores of PAS indicate poorer func-
tion. PAS also assesses socio sexual aspect after age 15
but this item was excluded from application because of
cultural differences.
Remission was measured according to criteria of
A n d r e a s e ne ta l[ 1 9 ] .F u l lr e m i s s i o ni sd e f i n e da s
achievement of remission on 8 symptoms from PANSS
at any point of follow up and persistence for 6 months.
These criteria were identified by factor analysis of
PANSS and included 8 items which are delusions, unu-
sual thought content, hallucinatory behavior, concep-
tual disorganization, mannerisms/posturing, blunted
affect, social withdrawal and lack of spontaneity [19].
Partial remission was defined as presence of evidence
of significant clinical improvement with less severe
symptoms persisting (50% improvement from the base-
line) [19,20].
Level of education was considered; average if the
patient achieves his/her suspected educational grade,
mild to moderate if there is delay 1-3 years less than
same age colleagues, severe if there is delay more than 3
years.
The investigators put three outcome categories
according to the best level of function (highest score of
CGAS) in addition to remission status; Good out come
if patients achieve remission and CGAS was ≥ 70. Mod-
erate outcome if CGAS between 40-70 with full or par-
tial remission. Poor outcome if CGAS ≤ 40 and partial
or no remission.
Positive consanguinity was only considered in case of
second degree consanguinity as defined by common law
(uncle, Cousin). Similarly family history considered posi-
tive only in case of first and second degree (one parent,
one sib or first cousin) [21].
Details about obstetric history and early development
can be subjected to different kinds of bias such as recall
bias or recency effect. In the current study we tried to
minimize these effects through depending on retrieving
the information from more than one source (family
members, medical reports, etc) but definitely we didn’t
e x c l u d eb i a sc o m p l e t e l ya n dt h i sm a yb et h ec a s ei n
most of previous studies concerned with retrospective
data.
Also the investigators used some operational defini-
tions; Duration of illness was measured from onset of
symptoms till last follow up in months. Duration of fol-
low up was measured from first visit to clinic till the
last visit within the study duration. Duration to
improvement was measured from onset of symptoms till
full remission or 50% response if no remission. Duration
of untreated psychosis was measured from the onset of
first psychotic symptoms to the start of treatment.
Patients were considered adherent if missed doses were
less than 25% of doses all through duration of follow up.
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Analysis of the data was done by using statistical pro-
gram for social science (SPSS) version 10. The statisti-
c i a nc h o s es u i t a b l em e a s u r e sf o rt h es i z eo ft h es a m p l e
to reduce attrition rate, mainly descriptive statistics, Chi
square and cross stab for analysis of categorical vari-
ables. Mann Whitney and Kruskal-Wallis test were used
to compare quantitative variables in the same group
instead of independent group t-test and one way
between groups ANOVA because of the non-parametric
criteria of the data (SD > 50% mean). Spearman’sr a n k
correlation was also used. Logistic regression was used
to detect possible predictor factors for remission and or
outcome.
Results
Demographic and clinical characteristics
Out of 56 patients (26 males and 30 females) only 37
(14 males and 23 females) completed the minimum
duration and follow up visits of the study. Mean age of
patients 17 +/- 3.7, while mean age of onset of psychosis
was 12.2 +/- 3.7. Thirty patients were diagnosed as schi-
zophrenia (14 paranoid, 8 undifferentiated, 8 hebephre-
nic) and 7 with psychotic disorder not otherwise
specified. The onset of illness was acute in 16 patients
(43.2%) and gradual in 21 patients (56.8%). Mean IQ of
the sample was 87.4 +/- 22 although 8 patients (21.6%)
were in the category of mental retardation. In addition
mean duration of illness was 61 +/- 39.9 months, mean
duration of follow up was 38.4 +/- 16.9 months. Mean
duration of untreated psychosis was 17.6 +/- 28 months.
Diagnosis and Drop out
All findings regarding diagnoses and dropout can be
found in table 1. Nineteen (33.9%) patients of the origi-
nal sample didn’t complete the study. Five patients were
given different diagnoses during follow up (1 bipolar
disorder, 2 schizoaffective and 2 substance induced psy-
chosis) and 14 patients either didn’t complete the mini-
mum duration, visits and/or required tools. Comparing
dropout to those who complete the study regarding, age
of onset, sex, personal and family history, diagnosis,
initial PANSS score and CGAS show no significant dif-
ference except for diagnosis as dropout was more
among non schizophrenic group (P = 0.022).
In addition, table 1 gave an idea about diagnostic sta-
bility in the sample. Out of 5 patients with acute psy-
chotic episode (APE) no one continued the study either
due to drop out or change of diagnosis, while 7 patients
out of 22 patients with psychotic disorder not otherwise
specified (PDNOS) continued with the same diagnosis.
Consequently number of schizophrenic increased from
29 to 30 patients at the end of the study.
Past history and family history
Consanguineous marriage was found in 17 patients
(45.9%) from the sample. In addition, 16 patients
(43.2%) had positive family history of schizophrenia and
5 patients (13.5%) had family history of other psychiatric
illness. Table 2) showed relation between family history
and remission status and different groups of outcome,
however there was no statistically significant difference.
Furthermore, 17 patients (45.9%) had positive past his-
tory of psychiatric illness (7 mental retardation, 3 aut-
ism, 1 autism with mental retardation, 4 anxiety
disorders and 2 conduct disorder).
As shown in table 3, the age of onset of psychosis and
its mode of onset were significantly related to early
development and premorbid functions (GDS, CBS and
PAS). Moreover, early development and premorbid
functions (GDS, CBS, and PAS) were significantly
related to psychotic symptoms (positive and negative)
while current functioning (CGAS) was significantly
related to negative symptoms and GPS.
As shown in table 3, more impairment in premorbid
function as indicated by PAS is associated with more
negative symptoms, which appear to affect the current
functioning as shown by GAS. At the same time, the
developmental and behavioral problems predating onset
of psychosis (GDS, CBS) were significantly correlated to
severity of psychotic symptoms, mode of onset and age
of onset rather than current functioning (GAS).
Outcome measures
At the end of the study 6 patients (16.2%) had only one
episode, 11 patients (29.7%) had multiple episodes with-
out deficit, 12 patients (32.4%) had multiple episodes
with deficits and 8 patients (21.6%) had continuous
course. Data regarding outcome measures are all sum-
marized in table 4. Regarding remission; 19 patients
Table 1 Diagnosis and dropout
Items Number
Original sample size 56
Drop out 14
Exclusion
due to
change of diagnosis
Bipolar disorder 1
Schizoaffective 2
Substance induced psychosis 2
Schizophrenia at last visit 30
Schizophrenia at first visit 29
PDNOS at last visit 7
PDNOS at first visit 22
Acute psychotic episode at last visit 0
Acute psychotic episode at first visit 5
PDNOS: psychotic disorder not otherwise specified
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partial remission and 9 patients (24.3%) had no or little
improvement. Mean duration till improvement (or
remission) was 12.4 +/- 10.1 months, full remission
achieved within 10.4 +/- 8.8 months. Regarding educa-
tional level at the end of follow up period; only 11
patients (29.7%) achieved their average educational level
for their age while 15 patients (40.5%) had mild to mod-
erate delay and 11 patients (29.7%) had severe delay.
Although the policy of the hospital didn’t allow admis-
sion before age 16 years, 10 patients (27%) of were
grossly disturbed that necessitate admission.
Comparisons between remittent and non remittent
groups of patients found that there are many factors sig-
nificantly affect the remission status as the diagnosis,
onset of the illness and educational level. All these vari-
ables are presented in table 5. Comparison of remittent
to non remittent patients showed statistically significant
differences as remission was more with cases of acute
onset of illness and good adherence to drugs. In addi-
tion, remission was more among patients of paranoid
schizophrenia and PDNOS.
Regarding categories of family history, there was no
statistically significant difference between patients with
positive family history and those with negative family
history regarding remission status. Family history was
positive for other psychiatric disorders only in 5 cases.
Two cases of them were positive for mood disorders,
one case was positive for mental retardation, one case
for substance induced psychosis and the last case was
positive for OCD.
Also comparisons between remittent and non remit-
tent patients as regard continuous variables showed
some significant differences as summarized in table 6.
As remittent group had older age of onset and better
premorbid functions, in addition to less negative symp-
toms and better IQ.
Spearman correlation showed many factors signifi-
cantly associated with remission as older age of onset (r
= .354, P = .032) and less score on child behavior scale
(CBS), general developmental scale (GDS) and premor-
bid adjustment scale (PAS) as (r = -.396 - P = .015), (r =
-.327 P = .048) and (r = -.405 P = .013) respectively.
Also, remission was associated significantly with higher
IQ (r = .325, P = .050), less negative symptoms (r =
-.375, P = .022) and compliance (r = -.355, P = 0.033).
Moreover, shorter duration of untreated psychosis
(DUP) and duration to improvement were significantly
associated with remission state as (r = -.284 P = .088)
and (r = -.328 P = .082) respectively.
Regarding outcome
Also comparisons of groups of patients with different
outcomes revealed some significant differences which
are summarized in table 7. There were significant differ-
ence between groups as good outcome group had better
PAS, less negative symptoms, less GPS score and better
IQ. In addition good outcome were more in patients
with PDNOS and paranoid schizophrenia rather than
disorganized and undifferentiated schizophrenia.
Spearman correlation showed that many factors were
significantly associated with good outcome as shorter
duration to improvement (r = .419, P = .024), higher IQ
(r = -.450, P = 0.005), less score on PAS (r = .595, P =
0.000), less negative symptoms (r = .506, P = 0.001),
negative past history (r = .342, P = 0.038), acute onset (r
Table 2 Showed relation between family history and remission status and different groups of outcome
FH Remission Non remission Good outcome Moderate
outcome
Poor
outcome
Negative 10 (62.5%) 6 (37.5%) 5 (31.3%) 8 (50%) 3 (18.7%)
Schizophrenia 7 (43.8%) 9 (56.3%) 5 (31.3%) 5 (31.3%) 6 (37.5%)
Other 1 (20%) 4 (80%) 0 (0%) 5(100%) 0 (0%)
P .220 .098
Table 3 Correlation between premorbid state and PANSS, GAS, mode of onset and age of onset (r-value)
Premorbid function PANSS GAS Mod of onset Age of onset
Positive Negative GPS
GDS -0.4** 0.2 -0.2 -0.09 .2 -0.5**
CBS -0.3* 0.3* -0.2 -0.1 .5** -0.5**
PAS -0.2 0.6** -0.007 -0.3* .4** -0.5**
CGAS -0.2 -0.4** -0.4** ——— -.1 -0.02
Age of onset 0.3* -0.05 0.2 -0.02 -.3* ————
NB: * indicates significant p < 0.1; ** indicated highly significant p < 0.01
GDS: General developmental scale; CBS: Child behavior scale; PAS: Premorbid adjustment scale; GAS: Global assessment scale; GPS: General psychopathology
scale.
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P = 0.040).
One of the two factors constitutes the outcome in the
current study was the remission status that’sw h yt h e r e
was highly significant differences between cases of single
and remittent episodes in comparisons to cases of con-
tinuous course as shown in table 8.
Ten cases of single and remittent patients had good
outcome and 8 cases had moderate outcome. While
none of the cases with continuous course achieved good
outcome. Moreover, the difference between the two
groups of course as regard outcome was highly signifi-
cant as P value was 0.013.
Logistic regression
Binary logistic regression for possible predictors of
remission revealed no significance as indicated by P =
.814 (variables entered were PAS, Age of onset, negative
symptoms and compliance). Also, binary logistic regres-
sion for outcome revealed no significance of the selected
variables (PAS, negative symptoms and IQ). However,
there was a tendency of negative symptoms to predict
poor outcome as P value was 0.051.
Discussion
The results of current study showed that 27% of patients
with early onset psychosis can behave and function
properly after few years from start of the illness as indi-
cated by the remission of important brain and beha-
vioral dysfunctions, good score on global assessment
scale and average academic achievement in their educa-
tion. Also, 48% of patients achieve moderate outcome
and only 25% achieve poor outcome.
Regarding socio-demographic characteristics of the
sample, those who complete the study were 37 patients,
14 males and 23 females. This discrepancy between
number of females versus males was not statistically sig-
nificance (df = 1 and P = .139). During follow up drop-
out was more in male group but still without statistical
significance (df = 1, P = 0.075).
There was controversial findings regarding gender in
previous studies as some studies reported male
Table 4 Showed outcome measures
Outcome measures Items Number (%)
Remission Full remission 19 (51.4%)
Partial remission 9 (24.3%)
No remission 9 (24.3%)
Educational level Average 11 (29.7%)
Mild delay 15 (40.5%)
Sever delay 11 (29.7%)
Course Single - Episodic 15 (40.5%)
Remission & exacerbation 13 (35.2%)
Continuous 9 (24.3%)
Outcome Good 10 (27%)
Moderate 18 (48.6%
Poor 9 (24.3%)
Table 5 Showed comparisons between remittent and non
remittent groups
Items Remittent
Number
(%)
Non
remittent
Number
(%)
P
Sex Male 6 (42.9) 8 (57.1) 0.42
Female 13 (56.5%) 10 (43.5%)
Diagnosis Paranoid 10 (71.4%) 4 (28.6%) 0.006
Undifferentiated 1 (12.5%) 7 (87.5%)
Disorganized 2 (25%) 6 (75%)
Atypical psychosis 6 (85.7%) 1 (14.3%)
PH Positive 6 (35%) 11 (65%) 0.296
Negative 13 (65%) 7 (35%)
FH Schizophrenia 7 (43.8%) 9 (56.3%) 0.419
Negative for
schizophrenia
12 (57.1%) 9 (42.9%)
Onset Acute 12 (75%) 4 (25%) 0.012
Gradual 7 (33.3%) 14 (66.7%)
Compliance Adherent 14 (70%) 6 (30%) 0.014
Poor adherence 5 (29.4%) 12 (70.6%)
Educational
level
Average 10 (90.9%) 1 (9.1%) 0.006
Mild delay 6 (40%) 9 (60%)
Severe delay 3 (27.3%) 8 (72.7%)
PH: past history; FH: family history
P value is significant if ≤ 0.05; P value is highly significant if ≤ 0.005
Table 6 Comparison between remittent and non-
remittent regarding continuous variables:
Variables Remittent Non remittent P value
Age of onset 13.5 +/- 3.3 11.1 +/- 3.7 0.03
GDS 1.5 +/- 2.5 3.4 +/- 3.3 0.05
CBS 4.9 +/- 4.7 8.3 +/- 3.9 0.02
PAS 9.7 +/- 5.2 14 +/- 4.9 0.01
DUP 9 +/- 9.8 27.9 +/- 43.9 0.092
Duration to improvement 10.4 +/- 8.8 21 +/- 20.3 0.092
Positive subscale 28.5 +/- 8.9 26.8 +/- 5.8 0.538
Negative subscale 25.5 +/- 11.3 34 +/- 10.1 0.024
GPS 56.8 +/- 12.2 54.7 +/- 16.1 0.408
IQ 93 +/- 25.1 82 +/- 17.5 0.04
GDS: general development scale; CBS: child behavior scale
PAS: premorbid adjustment scale; DUP: Duration of untreated psychosis
GPS: General psychopatrhology subscale from PANSS
IQ: Intelligent quotient; P value is significant if ≤ 0.05
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showed female predominance [24,25]. Also, some stu-
dies found no gender difference [26]. Differences
between studies may be the result of referral bias as
reported by Hollis ‘s study [11].
Fifteen patients (40.5%) of the sample had only one
episode, 13 patients (35.2%) had episodic course with no
deficit and 9 patients (24.3%) had continuous course.
During period of follow up 51.4% of the sample
achieved remission while 24.3% showed partial remis-
sion and 24.3% showed little or no improvement. Com-
paring remittent to non remittent patients, remission
was more among patients of psychotic disorder not
otherwise specified and paranoid schizophrenia. More-
over, remission was more in patients with acute onset
and good adherence to drugs.
Twenty seven percent of the sample (10 patients) had
good outcome. This result was similar to Asarnow et al
study [27] who reported a good level of psychosocial
functioning in 28% of the cases.
The current study showed that 24.3% of the sample (9
patients) had poor outcome, while 45% of the sample of
Asranow et al study [27] showed deteriorating course
and minimal improvement.
Moreover, the results of the current study were better
than that of Maziade and his colleagues [8], as only 5%
of the sample in this study achieved full recovery after a
mean follow-up interval of 14.8 years, with poor or very
poor outcome in 74% of the sample.
Remschmidt et al study [28] examined the outcome of
very early onset schizophrenia before age 14 years after
a mean time span of 42 years and they found that 60%
of patients had poor outcome and only 24% showed
moderate global outcome.
These results were relatively better than study of
Eggers and Bunk [24] who reassessed 44 inpatients after
a long follow-up interval of 42 years and found only
25% of cases with full remission and another were 25%
with partial remission and about 50% were poorly
remitted.
Although there are a lot of methodological differences
between the current study and those mentioned studies,
it seems that the longer the duration of the study the
more badly the outcome.
Table 7 Comparison between groups with different outcomes regarding clinical and premorbid variables:
Variables Good outcome Moderate outcome Poor outcome P value
Age of onset 12.5 +/- 4.1 12.8 +/- 3.7 10.8 +/- 3.2 .255
Sex
Male 3 (21.4%) 6 (42.9%) 5 (35.7%) .445
Female 7 (30.4%) 12 (52.2%) 4 (17.4%)
GDS 0.7 +/- 0.82 3.3 +/- 3.2 2.9 +/- 2.7 .165
CBS 4.7 +/- 5 7.5 +/- 4.7 7.1 +/- 3.1 .231
PAS 7.4 +/- 2.4 12.7 +/- 5.4 15.3 +/- 4.8 .002
DUP 12.1 +/- 10.5 20.2 +/- 42.6 23.2 +/- 29.7 .410
Duration to improvement 7.1 +/- 3.2 14.6 +/- 10.7 38 +/- 33 .082
Positive subscale 28.8 +/- 8.2 26 +/- 6.4 29.7 +/- 6.2 .343
Negative subscale 21.1 +/- 9.7 31.3 +/- 11 36.8 +/- 8.2 .009
GPS 57.7 +/- 12.7 50 +/- 12.4 65 +/- 14.8 .030
IQ 105.8 +/- 10.1 80.8 +/- 21.4 80 +/- 22.4 .008
Diagnosis
Paranoid 5(35.7%) 7(50%) 2(14.3%) .040
Undifferentiated 1(12.5%) 5(62.5%) 2(25%)
Disorganized 0(0%) 3(37.5%) 5(62.5%)
PDNOS 4(57.1%) 3(42.9%) 0(0%)
GDS: general development scale; CBS: child behavior scale
PAS: premorbid adjustment scale; DUP: Duration of untreated psychosis
GPS: General psychopathology subscale from PANSS; IQ: Intelligent quotient
P value significant if ≤ 0.05; P value is highly significant if ≤ 0.005
PDNOS: Psychotic disorder not otherwise specified
Table 8 Showed relation between outcome and course
Course Good
outcome
Moderate
outcome
Poor
outcome
P
Single/
remittent
10 (100%) 8 (44.4%) 0 (0%) 0.003
Continuous 0 (0%) 10 (55.6%) 9 (100%)
Hassan and Taha Behavioral and Brain Functions 2011, 7:28
http://www.behavioralandbrainfunctions.com/content/7/1/28
Page 7 of 10Another important aspects of psycho-social outcome
investigated in previous studies were education, living
conditions and occupational situation. In spite of short
duration of the current study, 29.7% of the sample (n =
11) achieved their average educational level for their
age. Similarly Remschmidt and his colleagues [28]
reported that 74% of patients failed to graduate from
any school and 71% were unemployed.
Comparing remission status to outcome status in the
current study, 51.4% of the sample achieved remission
but only 27% considered as good outcome group.
Relatively better remission rate and outcome in the
current study than previous studies [8,24,27,28] may be
due to shorter duration of follow up, different clinical
characteristics of the sample, different outcome mea-
sures and remission criteria used. Use of social outcome
measures and quality of life scales in those patients may
reflect the poorest outcome measures.
Another possible explanation for better outcome in
the current study is the environment in which the study
w a sd o n e .T h i ss t u d yw a sd o n ei nad e v e l o p i n gc o u n t r y
and many studies found that outcome of adult schizo-
phrenia is better in developing than developed countries
[29,30]. So it may be more tolerance and acceptance of
psychotic people and better family cohesion in develop-
ing countries rather than actual better global outcome
of schizophrenia.
However recent data from worldwide-schizophrenia
outpatient health outcomes (W-SOHO) study in 2009
reported that with a few exceptions, the W-SOHO study
baseline findings generally show substantial similarity in
outcome across countries representing various world
regions outside of North America including 196 patients
from Saudi Arabia [31].
Possible predictors for remission and outcome
In this study, factors associated significantly with remis-
sion were older age of onset of psychosis, better pre-
morbid functions (as measured by CBS, GDS, PAS and
IQ), lesser negative symptoms at start of illness and
more adherence to treatment. Although there were sig-
nificant association between remission and previous fac-
tors however none of them could be considered as
predictor for it, as logistic regression showed no
significance.
In the current study, in spite of the high rate of posi-
tive consanguinity and positive family history we
couldn’t demonstrated the effect of this genetic load on
outcome of our sample, these may be due to small sam-
ple size with different categories of family history and
outcome.
On the other hand, factors associated with good out-
c o m ei nt h ec u r r e n ts t u d yw e r eg o o dp r e m o r b i df u n c -
tion (lower score of PAS), negative past history, higher
IQ, acute onset, lesser negative symptoms, good adher-
ence to drugs and shorter duration to improvement
(Table 6). There was tendency of negative symptoms to
predict poor outcome.
Similar associated factors or predictors were found in
previous studies as age at onset of the disorder
[2,24,32], the type of onset acute versus chronic [24,33],
premorbid adjustment [6,7,34] and lower scores of nega-
tive symptoms [11]. Furthermore, previous studies
reported IQ as strong predictor of social outcome [35].
Another possible predictor for remission first investi-
gated by Hollis [36] was early course over the first 6
months or as defined in the current study “time to
improvement”.
Although DUP was one of the possible predictors in
some previous studies of adult onset psychosis, it was
not the case in the current study. This finding may be
similar to Beng-Choon et al [9] and it means that dura-
tion of untreated initial psychosis is not a prognostic
factor for outcome early in the course of schizophrenia,
however this point still in need for further analysis and
research.
Furthermore, some cases in the current study had
concomitant intellectual disability or autism and this
can certainly affect the clinical outcomes and longitudi-
nal progress. However, schizophrenia is a neurodevelop-
mental disorder and premorbid symptoms are common
especially in early onset cases. Previous studies similarly
included patients with positive past history [32,37].
Regarding MR, several studies have found a mean IQ
between 80 and 85 (one standard deviation below the
population mean), with about one-third of cases having
an IQ below 70 [36,38,39]. So some authors consider
low IQ as one of the vulnerability factors for schizo-
phrenia and others consider it as an expression of
impaired early brain development [40]. For sure these
comorbidities impact the outcome of psychosis but
clinically cleaning up of the sample and removal of such
impacts is extremely difficult in naturalistic prospective
studies. Moreover, sample heterogeneity and comorbid-
ities give readers more chance to generalize the results
to all cases of early onset non affective psychosis.
Strengths and limitations
In spite of the fact that, low or middle-income countries
represent more than 85% of the world’s population, only
6% of publications come from it [41]. Prospective longi-
tudinal research in Middle Eas tc o u n t r i e si sm i n i m a li f
any because of many logistic problems. Moreover,
research in the field of outcome of early onset psychosis
is scanty. That’s why the current study is a unique pro-
spective naturalistic study of childhood and adolescent
onset psychosis. Prospective design of the study allowed
the comment on course and inter-episodic periods and
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tration bias of retrospective studies. In addition the
investigators used a lot of valid tools in initial assess-
ment and all through follow up (K-SAD PL, PAS,
PANSS and CGAS) to strengthen the results. Also,
Initial assessment and clinical tools were done by 2
child psychiatrists with good inter rater reliability. More-
over, the current study focused on previously discussed
predictive factors for outcome together with emphasis
on possible new outcome measures as time to improve-
ment and compliance.
However due to prospective design there was high rate
of drop out (33.9%) from the original sample. Further-
more, in comparisons to other outcome studies [4,7,28]
t h em e a nd u r a t i o no fi l l n e s sa n df o l l o wu pi nt h ec u r -
rent study was shorter (61 +/- 39.9 and 38.4 +/- 16.9
months respectively). That’s why this work was an inter-
mediate term outcome study.
Diagnostic heterogeneity within the subject weakened
the power and focus of the study but on the other side
this heterogeneity may be considered a strong point for
two reasons. The first, the subjects here were a natura-
listic sample from real life clinical practice and gave an
idea about the outcome in all cases of early onset non
affective psychosis whatever the system of classification
used and whatever the heterogeneity or comorbidity.
The second reason, psychosis is a continuum and the
demarcation between cases currently used in psychiatry
is a bias because of its dependence on categorical classi-
fication without any relation to any biological etiology.
Moreover, many of previous studies included other diag-
noses [3,4,6,17,36]
Conclusion
Remission and good outcome of behavioral and brain
dysfunctions of patients with early onset non affective
psychosis is attainable. There are some factors that
consistently related to remission and good outcome
which were acute onset, higher IQ, good premorbid
adjustment, less negative symptoms at start of the ill-
ness and good adherence to medications. In addition,
there is tendency of negative symptoms at illness start
to predict outcome. Also, the study put a question
mark on the role of DUP on remission and outcome
with new emphasis on the role of duration to improve-
ment. However, screening of high risk children as
those with low IQ, poor premorbid adjustment and
positive family history for psychosis might help in
early detection. Optimum intervention and strategies
to improve compliance and negative symptoms are key
points in both remission and good outcome. Although
remission is a difficult target in childhood psychosis, it
is still achievable.
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